Medications for Leukemia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Leukemia.
Found 54 Approved Drugs for Leukemia
Cytarabine
Generic Name
Cytarabine
Cytarabine
Generic Name
Cytarabine
Form: Injection
Method of administration: Intravenous, Subcutaneous, Intrathecal
FDA approval date: June 04, 1990
Classification: Nucleoside Metabolic Inhibitor
Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of Cytarabine Injection is indicated in the prophylaxis and treatment of meningeal leukemia.
AzaCITIDine
Brand Names
Vidaza, Onureg
AzaCITIDine
Brand Names
Vidaza, Onureg
Form: Injection, Tablet
Method of administration: Subcutaneous, Intravenous, Oral
FDA approval date: July 05, 2004
Classification: Nucleoside Metabolic Inhibitor
Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of: · Adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Twyneo, Atralin, ZIANA, Tri-Luma, Vesanoid, Clindagel, Retin-A, Acanya, Renova, Onexton
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Twyneo, Atralin, ZIANA, Tri-Luma, Vesanoid, Clindagel, Retin-A, Acanya, Renova, Onexton
Form: Solution, Lotion, Injection, Suppository, Cream, Aerosol, Kit, Granule, Powder, Swab, Capsule, Gel
Method of administration: Oral, Intravenous, Vaginal, Intramuscular, Topical
FDA approval date: May 22, 1970
Classification: Lincosamide Antibacterial
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is a combination tretinoin, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. ( 1 )
RiTUXimab
Brand Names
Rituxan, Ruxience, Riabni, Rituxan Hycela, Truxima
RiTUXimab
Brand Names
Rituxan, Ruxience, Riabni, Rituxan Hycela, Truxima
Form: Injection
Method of administration: Subcutaneous, Intravenous
FDA approval date: November 26, 1997
Classification: CD20-directed Cytolytic Antibody
RITUXAN is a CD20-directed cytolytic antibody indicated for the treatment of: Adult patients with Non-Hodgkin's Lymphoma (NHL).
Daunorubicin
Generic Name
Daunorubicin
Daunorubicin
Generic Name
Daunorubicin
Form: Injection
Method of administration: Intravenous
FDA approval date: January 02, 2018
Classification: Anthracycline Topoisomerase Inhibitor
Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
Showing 1-5 of 54
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances